Increased vascular endothelial growth factor mRNA expression in the heart of streptozotocin-induced diabetic rats

Metabolism: Clinical and Experimental

Volumn 52, Issue 6, 2003, Pages 675-678

  Sasso, Ferdinando Carlo ^a   Carbonara, O ^a   Persico, E ^a   D'Ambrosio, R ^a   Coppola, L ^a   Nasti, R ^a   Campana, B ^a   Moschella, S ^a   Torella, R ^a   Cozzolino, D ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FETAL LIVER KINASE 1; FMS LIKE TYROSINE KINASE 1; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KETAMINE; MESSENGER RNA; STREPTOZOCIN; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR; XYLAZINE; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DENSITOMETRY; DIABETES MELLITUS; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HEART; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR DISEASE; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HEART MUSCLE; METABOLISM;

ANIMALS; DENSITOMETRY; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL GROWTH FACTORS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MYOCARDIUM; POLYMERASE CHAIN REACTION; RATS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0042873020     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00064-7     Document Type: Article

References (18)

1. Leung DW, Cachianes G, Kuang WJ, et al: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309, 1989
2. Shweiki D, Itin A, Soffer D, et al: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992
3. Neufeld G, Cohen T, Gengrinovitch S, et al: Vascular endothelial growth factor and its receptors. FASEB J 13:9-22, 1999
4. Cooper ME, Vranes D, Youssef S, et al: Increased renal expression of vascular endothelial growth factor and its receptor VEGFR-2 in experimental diabetes. Diabetes 48:2229-2239, 1999
5. Matsunaga T, Warltier DC, Weihrauch DW, et al: Ischemia induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102:3098-3103, 2000
6. Shinohara K, Shinohara T, Mochizuki N, et al: Expression of vascular endothelial growth factor in human myocardial infarction. Heart Vessels 11:113-122, 1996
7. Waltenberger J, Lange J, Kranz A: Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus. Circulation 102:185-190, 2000
8. Belgore FM, Lip GYH, Lip PL, et al: Elevated levels of vascular endothelial growth factor (VEGF) and its receptor (sFlt-1) in diabetes. Eur Health J 21:P3487, 2000 (suppl, abstr)
9. Chou E, Suzuma I, Way KJ, et al: Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states. Circulation 105:373-379, 2002
10. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
11. Nahser PJJ, Brown RE, Oskarsson H, et al: Maximal coronary flow reserve and metabolic coronary vasodilatation in patients with diabetes mellitus. Circulation 91:635-640, 1995
12. Aronson D, Rayfield EJ, Chesebro JH: Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 126:296-306, 1997
13. Waltenberger J, Lange J, Frank H, et al: The cellular response to VEGF-a is attenuated in diabetes mellitus in vivo and hyperglycemia in vitro. Circulation 102:882, 2000 (suppl S. abstr)
14. Natarajan R, Bai W, Lanting L, et al: Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol 273:H2224-H2231, 1997
15. Losordo DW, Vale PR, Symes JF, et al: Gene therapy for myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98:2800-2804, 1998
16. Gilbert RE, Wilkinson-Berka JL, Johnson DW, et al: Renal expression of transforming growth factor-β inducible gene-h3 (β-ig-h3) in normal and diabetic rats. Kidney Int 54:1052-1062, 1998
17. Mandriota SJ, Menoud PA, Pepper MS: Transforming growth factor β-1 downregulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J Biol Chem 271:11500-11505, 1996
18. Pertovaara L, Kaipainen A, Mustonen T, et al: Vascular endothelial growth factor is indiced in response to transforming growth factor-β in fibroblast and epithelial cells. J Biol Chem 269:6271-6274, 1994